HIGHLIGHTS
- who: Mohamed Mohany et al. from the Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, POBox, Riyadh, Saudi Arabia have published the research work: The Role of NF-B and Bax/Bcl-2/Caspase-3 Signaling Pathways in the Protective Effects of Sacubitril/Valsartan (Entresto) against HFD/STZ-Induced Diabetic Kidney Disease, in the Journal: Biomedicines 2022, 10, x FOR PEER REVIEW of /2022/
- what: The aim of the current experiment is to investigate the potential protective benefits and mechanisms of LCZ696 against DKD in a well-established rat model of experimental . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.